Processa Pharmaceuticals, Inc. (PCSA) Capital expenditures 2016–2024
Processa Pharmaceuticals, Inc. (PCSA) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$3,244FY2024 · since FY2016: $23,775 → $3,244
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $3,244 | +16.9% |
| FY2023 | $2,776 | — |
| FY2017 | $20,622 | -13.3% |
| FY2016 | $23,775 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice